Amicus Therapeutics, Inc. (FOLD): Are Hedge Funds Right About This Stock?

Page 2 of 2
Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
Cytokinetics, Inc. (NASDAQ:CYTK) 7 0 1
ArQule, Inc. (NASDAQ:ARQL) 13 0 0
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) 6 1 0
Pain Therapeutics, Inc. (NASDAQ:PTIE) 11 0 0
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) 9 2 2

With the returns exhibited by our time-tested strategies, everyday investors should always keep an eye on hedge fund and insider trading activity, and Amicus Therapeutics, Inc. (NASDAQ:FOLD) shareholders fit into this picture quite nicely.

Click here to learn why you should track hedge funds

Page 2 of 2